Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines

A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines

Thumbnail Image
Download
Name

nihms-1905817.pdf

Description
Accepted version
Size

4.66 MB

Format

Adobe PDF

Checksum (MD5)

c190c73caac10248c68a883fc3e49048

sword-2025-10-14T21:10:50.original.xml (130 B)
Original SWORD entry document
Author(s)
vander Straeten, Aurélien
•
Sarmadi, Morteza
•
Daristotle, John L
•
Kanelli, Maria
•
Tostanoski, Lisa H
•
Collins, Joe
•
Pardeshi, Apurva
•
Han, Jooli
•
Varshney, Dhruv
•
Eshaghi, Behnaz
more
Date Issued
April 24, 2024
Journal
Nature Biotechnology
Publisher
Springer Science and Business Media LLC
Citation
vander Straeten, A., Sarmadi, M., Daristotle, J.L. et al. A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines. Nat Biotechnol 42, 510–517 (2024).
Version
Author's final manuscript
Abstract
Decentralized manufacture of thermostable mRNA vaccines in a microneedle patch (MNP) format could enhance vaccine access in low-resource communities by eliminating the need for a cold chain and trained healthcare personnel. Here we describe an automated process for printing MNP Coronavirus Disease 2019 (COVID-19) mRNA vaccines in a standalone device. The vaccine ink is composed of lipid nanoparticles loaded with mRNA and a dissolvable polymer blend that was optimized for high bioactivity by screening formulations in vitro. We demonstrate that the resulting MNPs are shelf stable for at least 6 months at room temperature when assessed using a model mRNA construct. Vaccine loading efficiency and microneedle dissolution suggest that efficacious, microgram-scale doses of mRNA encapsulated in lipid nanoparticles could be delivered with a single patch. Immunizations in mice using manually produced MNPs with mRNA encoding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein receptor-binding domain stimulate long-term immune responses similar to those of intramuscular administration.
MIT Department
Koch Institute for Integrative Cancer Research at MIT
Massachusetts Institute of Technology. Department of Chemical Engineering
Ragon Institute of MGH, MIT and Harvard
Terms of Use
Creative Commons Attribution-Noncommercial-ShareAlike
http://creativecommons.org/licenses/by-nc-sa/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/163167
DOI of Published Version
https://doi.org/10.1038/s41587-023-01774-z
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.